1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global HIV-AIDS Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Kits and Reagents 1.2.3 Instruments 1.2.4 Others 1.3 Market by Application 1.3.1 Global HIV-AIDS Testing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Private Diagnostics Laboratories 1.3.4 Academic and Research Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global HIV-AIDS Testing Market Perspective (2017-2028) 2.2 HIV-AIDS Testing Growth Trends by Region 2.2.1 HIV-AIDS Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 HIV-AIDS Testing Historic Market Size by Region (2017-2022) 2.2.3 HIV-AIDS Testing Forecasted Market Size by Region (2023-2028) 2.3 HIV-AIDS Testing Market Dynamics 2.3.1 HIV-AIDS Testing Industry Trends 2.3.2 HIV-AIDS Testing Market Drivers 2.3.3 HIV-AIDS Testing Market Challenges 2.3.4 HIV-AIDS Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top HIV-AIDS Testing Players by Revenue 3.1.1 Global Top HIV-AIDS Testing Players by Revenue (2017-2022) 3.1.2 Global HIV-AIDS Testing Revenue Market Share by Players (2017-2022) 3.2 Global HIV-AIDS Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by HIV-AIDS Testing Revenue 3.4 Global HIV-AIDS Testing Market Concentration Ratio 3.4.1 Global HIV-AIDS Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by HIV-AIDS Testing Revenue in 2021 3.5 HIV-AIDS Testing Key Players Head office and Area Served 3.6 Key Players HIV-AIDS Testing Product Solution and Service 3.7 Date of Enter into HIV-AIDS Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 HIV-AIDS Testing Breakdown Data by Type 4.1 Global HIV-AIDS Testing Historic Market Size by Type (2017-2022) 4.2 Global HIV-AIDS Testing Forecasted Market Size by Type (2023-2028) 5 HIV-AIDS Testing Breakdown Data by Application 5.1 Global HIV-AIDS Testing Historic Market Size by Application (2017-2022) 5.2 Global HIV-AIDS Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America HIV-AIDS Testing Market Size (2017-2028) 6.2 North America HIV-AIDS Testing Market Size by Country (2017-2022) 6.3 North America HIV-AIDS Testing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe HIV-AIDS Testing Market Size (2017-2028) 7.2 Europe HIV-AIDS Testing Market Size by Country (2017-2022) 7.3 Europe HIV-AIDS Testing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific HIV-AIDS Testing Market Size (2017-2028) 8.2 Asia-Pacific HIV-AIDS Testing Market Size by Country (2017-2022) 8.3 Asia-Pacific HIV-AIDS Testing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America HIV-AIDS Testing Market Size (2017-2028) 9.2 Latin America HIV-AIDS Testing Market Size by Country (2017-2022) 9.3 Latin America HIV-AIDS Testing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa HIV-AIDS Testing Market Size (2017-2028) 10.2 Middle East & Africa HIV-AIDS Testing Market Size by Country (2017-2022) 10.3 Middle East & Africa HIV-AIDS Testing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Detail 11.1.2 Abbott Business Overview 11.1.3 Abbott HIV-AIDS Testing Introduction 11.1.4 Abbott Revenue in HIV-AIDS Testing Business (2017-2022) 11.1.5 Abbott Recent Development 11.2 Affymetrix 11.2.1 Affymetrix Company Detail 11.2.2 Affymetrix Business Overview 11.2.3 Affymetrix HIV-AIDS Testing Introduction 11.2.4 Affymetrix Revenue in HIV-AIDS Testing Business (2017-2022) 11.2.5 Affymetrix Recent Development 11.3 Beckman Coulter/Danaher 11.3.1 Beckman Coulter/Danaher Company Detail 11.3.2 Beckman Coulter/Danaher Business Overview 11.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Introduction 11.3.4 Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2017-2022) 11.3.5 Beckman Coulter/Danaher Recent Development 11.4 Becton Dickinson 11.4.1 Becton Dickinson Company Detail 11.4.2 Becton Dickinson Business Overview 11.4.3 Becton Dickinson HIV-AIDS Testing Introduction 11.4.4 Becton Dickinson Revenue in HIV-AIDS Testing Business (2017-2022) 11.4.5 Becton Dickinson Recent Development 11.5 bioMerieux 11.5.1 bioMerieux Company Detail 11.5.2 bioMerieux Business Overview 11.5.3 bioMerieux HIV-AIDS Testing Introduction 11.5.4 bioMerieux Revenue in HIV-AIDS Testing Business (2017-2022) 11.5.5 bioMerieux Recent Development 11.6 Bio-Rad 11.6.1 Bio-Rad Company Detail 11.6.2 Bio-Rad Business Overview 11.6.3 Bio-Rad HIV-AIDS Testing Introduction 11.6.4 Bio-Rad Revenue in HIV-AIDS Testing Business (2017-2022) 11.6.5 Bio-Rad Recent Development 11.7 Cepheid 11.7.1 Cepheid Company Detail 11.7.2 Cepheid Business Overview 11.7.3 Cepheid HIV-AIDS Testing Introduction 11.7.4 Cepheid Revenue in HIV-AIDS Testing Business (2017-2022) 11.7.5 Cepheid Recent Development 11.8 Diamedix 11.8.1 Diamedix Company Detail 11.8.2 Diamedix Business Overview 11.8.3 Diamedix HIV-AIDS Testing Introduction 11.8.4 Diamedix Revenue in HIV-AIDS Testing Business (2017-2022) 11.8.5 Diamedix Recent Development 11.9 DiaSorin 11.9.1 DiaSorin Company Detail 11.9.2 DiaSorin Business Overview 11.9.3 DiaSorin HIV-AIDS Testing Introduction 11.9.4 DiaSorin Revenue in HIV-AIDS Testing Business (2017-2022) 11.9.5 DiaSorin Recent Development 11.10 Eiken Chemical 11.10.1 Eiken Chemical Company Detail 11.10.2 Eiken Chemical Business Overview 11.10.3 Eiken Chemical HIV-AIDS Testing Introduction 11.10.4 Eiken Chemical Revenue in HIV-AIDS Testing Business (2017-2022) 11.10.5 Eiken Chemical Recent Development 11.11 Elitech Group 11.11.1 Elitech Group Company Detail 11.11.2 Elitech Group Business Overview 11.11.3 Elitech Group HIV-AIDS Testing Introduction 11.11.4 Elitech Group Revenue in HIV-AIDS Testing Business (2017-2022) 11.11.5 Elitech Group Recent Development 11.12 Enzo Biochem 11.12.1 Enzo Biochem Company Detail 11.12.2 Enzo Biochem Business Overview 11.12.3 Enzo Biochem HIV-AIDS Testing Introduction 11.12.4 Enzo Biochem Revenue in HIV-AIDS Testing Business (2017-2022) 11.12.5 Enzo Biochem Recent Development 11.13 Fujirebio 11.13.1 Fujirebio Company Detail 11.13.2 Fujirebio Business Overview 11.13.3 Fujirebio HIV-AIDS Testing Introduction 11.13.4 Fujirebio Revenue in HIV-AIDS Testing Business (2017-2022) 11.13.5 Fujirebio Recent Development 11.14 Lonza 11.14.1 Lonza Company Detail 11.14.2 Lonza Business Overview 11.14.3 Lonza HIV-AIDS Testing Introduction 11.14.4 Lonza Revenue in HIV-AIDS Testing Business (2017-2022) 11.14.5 Lonza Recent Development 11.15 Roche 11.15.1 Roche Company Detail 11.15.2 Roche Business Overview 11.15.3 Roche HIV-AIDS Testing Introduction 11.15.4 Roche Revenue in HIV-AIDS Testing Business (2017-2022) 11.15.5 Roche Recent Development 11.16 Scienion 11.16.1 Scienion Company Detail 11.16.2 Scienion Business Overview 11.16.3 Scienion HIV-AIDS Testing Introduction 11.16.4 Scienion Revenue in HIV-AIDS Testing Business (2017-2022) 11.16.5 Scienion Recent Development 11.17 Sequenom 11.17.1 Sequenom Company Detail 11.17.2 Sequenom Business Overview 11.17.3 Sequenom HIV-AIDS Testing Introduction 11.17.4 Sequenom Revenue in HIV-AIDS Testing Business (2017-2022) 11.17.5 Sequenom Recent Development 11.18 SeraCare 11.18.1 SeraCare Company Detail 11.18.2 SeraCare Business Overview 11.18.3 SeraCare HIV-AIDS Testing Introduction 11.18.4 SeraCare Revenue in HIV-AIDS Testing Business (2017-2022) 11.18.5 SeraCare Recent Development 11.19 Siemens 11.19.1 Siemens Company Detail 11.19.2 Siemens Business Overview 11.19.3 Siemens HIV-AIDS Testing Introduction 11.19.4 Siemens Revenue in HIV-AIDS Testing Business (2017-2022) 11.19.5 Siemens Recent Development 11.20 Takara Bio 11.20.1 Takara Bio Company Detail 11.20.2 Takara Bio Business Overview 11.20.3 Takara Bio HIV-AIDS Testing Introduction 11.20.4 Takara Bio Revenue in HIV-AIDS Testing Business (2017-2022) 11.20.5 Takara Bio Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global HIV-AIDS Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Kits and Reagents Table 3. Key Players of Instruments Table 4. Key Players of Others Table 5. Global HIV-AIDS Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global HIV-AIDS Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global HIV-AIDS Testing Market Size by Region (2017-2022) & (US$ Million) Table 8. Global HIV-AIDS Testing Market Share by Region (2017-2022) Table 9. Global HIV-AIDS Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global HIV-AIDS Testing Market Share by Region (2023-2028) Table 11. HIV-AIDS Testing Market Trends Table 12. HIV-AIDS Testing Market Drivers Table 13. HIV-AIDS Testing Market Challenges Table 14. HIV-AIDS Testing Market Restraints Table 15. Global HIV-AIDS Testing Revenue by Players (2017-2022) & (US$ Million) Table 16. Global HIV-AIDS Testing Market Share by Players (2017-2022) Table 17. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2021) Table 18. Ranking of Global Top HIV-AIDS Testing Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by HIV-AIDS Testing Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players HIV-AIDS Testing Product Solution and Service Table 22. Date of Enter into HIV-AIDS Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global HIV-AIDS Testing Market Size by Type (2017-2022) & (US$ Million) Table 25. Global HIV-AIDS Testing Revenue Market Share by Type (2017-2022) Table 26. Global HIV-AIDS Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global HIV-AIDS Testing Revenue Market Share by Type (2023-2028) Table 28. Global HIV-AIDS Testing Market Size by Application (2017-2022) & (US$ Million) Table 29. Global HIV-AIDS Testing Revenue Market Share by Application (2017-2022) Table 30. Global HIV-AIDS Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global HIV-AIDS Testing Revenue Market Share by Application (2023-2028) Table 32. North America HIV-AIDS Testing Market Size by Country (2017-2022) & (US$ Million) Table 33. North America HIV-AIDS Testing Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe HIV-AIDS Testing Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe HIV-AIDS Testing Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific HIV-AIDS Testing Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific HIV-AIDS Testing Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America HIV-AIDS Testing Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America HIV-AIDS Testing Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa HIV-AIDS Testing Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa HIV-AIDS Testing Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Company Detail Table 43. Abbott Business Overview Table 44. Abbott HIV-AIDS Testing Product Table 45. Abbott Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 46. Abbott Recent Development Table 47. Affymetrix Company Detail Table 48. Affymetrix Business Overview Table 49. Affymetrix HIV-AIDS Testing Product Table 50. Affymetrix Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 51. Affymetrix Recent Development Table 52. Beckman Coulter/Danaher Company Detail Table 53. Beckman Coulter/Danaher Business Overview Table 54. Beckman Coulter/Danaher HIV-AIDS Testing Product Table 55. Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 56. Beckman Coulter/Danaher Recent Development Table 57. Becton Dickinson Company Detail Table 58. Becton Dickinson Business Overview Table 59. Becton Dickinson HIV-AIDS Testing Product Table 60. Becton Dickinson Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 61. Becton Dickinson Recent Development Table 62. bioMerieux Company Detail Table 63. bioMerieux Business Overview Table 64. bioMerieux HIV-AIDS Testing Product Table 65. bioMerieux Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 66. bioMerieux Recent Development Table 67. Bio-Rad Company Detail Table 68. Bio-Rad Business Overview Table 69. Bio-Rad HIV-AIDS Testing Product Table 70. Bio-Rad Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 71. Bio-Rad Recent Development Table 72. Cepheid Company Detail Table 73. Cepheid Business Overview Table 74. Cepheid HIV-AIDS Testing Product Table 75. Cepheid Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 76. Cepheid Recent Development Table 77. Diamedix Company Detail Table 78. Diamedix Business Overview Table 79. Diamedix HIV-AIDS Testing Product Table 80. Diamedix Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 81. Diamedix Recent Development Table 82. DiaSorin Company Detail Table 83. DiaSorin Business Overview Table 84. DiaSorin HIV-AIDS Testing Product Table 85. DiaSorin Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 86. DiaSorin Recent Development Table 87. Eiken Chemical Company Detail Table 88. Eiken Chemical Business Overview Table 89. Eiken Chemical HIV-AIDS Testing Product Table 90. Eiken Chemical Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 91. Eiken Chemical Recent Development Table 92. Elitech Group Company Detail Table 93. Elitech Group Business Overview Table 94. Elitech Group HIV-AIDS TestingProduct Table 95. Elitech Group Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 96. Elitech Group Recent Development Table 97. Enzo Biochem Company Detail Table 98. Enzo Biochem Business Overview Table 99. Enzo Biochem HIV-AIDS TestingProduct Table 100. Enzo Biochem Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 101. Enzo Biochem Recent Development Table 102. Fujirebio Company Detail Table 103. Fujirebio Business Overview Table 104. Fujirebio HIV-AIDS TestingProduct Table 105. Fujirebio Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 106. Fujirebio Recent Development Table 107. Lonza Company Detail Table 108. Lonza Business Overview Table 109. Lonza HIV-AIDS TestingProduct Table 110. Lonza Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 111. Lonza Recent Development Table 112. Roche Company Detail Table 113. Roche Business Overview Table 114. Roche HIV-AIDS TestingProduct Table 115. Roche Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 116. Roche Recent Development Table 117. Scienion Company Detail Table 118. Scienion Business Overview Table 119. Scienion HIV-AIDS TestingProduct Table 120. Scienion Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 121. Scienion Recent Development Table 122. Sequenom Company Detail Table 123. Sequenom Business Overview Table 124. Sequenom HIV-AIDS TestingProduct Table 125. Sequenom Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 126. Sequenom Recent Development Table 127. SeraCare Company Detail Table 128. SeraCare Business Overview Table 129. SeraCare HIV-AIDS TestingProduct Table 130. SeraCare Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 131. SeraCare Recent Development Table 132. Siemens Company Detail Table 133. Siemens Business Overview Table 134. Siemens HIV-AIDS TestingProduct Table 135. Siemens Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 136. Siemens Recent Development Table 137. Takara Bio Company Detail Table 138. Takara Bio Business Overview Table 139. Takara Bio HIV-AIDS TestingProduct Table 140. Takara Bio Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Table 141. Takara Bio Recent Development Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. Global HIV-AIDS Testing Market Share by Type: 2021 VS 2028 Figure 2. Kits and Reagents Features Figure 3. Instruments Features Figure 4. Others Features Figure 5. Global HIV-AIDS Testing Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Private Diagnostics Laboratories Case Studies Figure 8. Academic and Research Institutes Case Studies Figure 9. Others Case Studies Figure 10. HIV-AIDS Testing Report Years Considered Figure 11. Global HIV-AIDS Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global HIV-AIDS Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global HIV-AIDS Testing Market Share by Region: 2021 VS 2028 Figure 14. Global HIV-AIDS Testing Market Share by Players in 2021 Figure 15. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2021) Figure 16. The Top 10 and 5 Players Market Share by HIV-AIDS Testing Revenue in 2021 Figure 17. North America HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America HIV-AIDS Testing Market Share by Country (2017-2028) Figure 19. United States HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe HIV-AIDS Testing Market Share by Country (2017-2028) Figure 23. Germany HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific HIV-AIDS Testing Market Share by Region (2017-2028) Figure 31. China HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America HIV-AIDS Testing Market Share by Country (2017-2028) Figure 39. Mexico HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa HIV-AIDS Testing Market Share by Country (2017-2028) Figure 43. Turkey HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia HIV-AIDS Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Abbott Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 46. Affymetrix Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 47. Beckman Coulter/Danaher Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 48. Becton Dickinson Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 49. bioMerieux Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 50. Bio-Rad Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 51. Cepheid Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 52. Diamedix Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 53. DiaSorin Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 54. Eiken Chemical Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 55. Elitech Group Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 56. Enzo Biochem Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 57. Fujirebio Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 58. Lonza Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 59. Roche Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 60. Scienion Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 61. Sequenom Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 62. SeraCare Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 63. Siemens Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 64. Takara Bio Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Abbott Affymetrix Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad Cepheid Diamedix DiaSorin Eiken Chemical Elitech Group Enzo Biochem Fujirebio Lonza Roche Scienion Sequenom SeraCare Siemens Takara Bio